SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
Journal of Psychopharmacology
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Geddes, J.
Right arrow Articles by Peet, M.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Geddes, J.
Right arrow Articles by Peet, M.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

The ratio of plasma phenylalanine to other large neutral amino acids is not a risk factor for tardive dyskinesia

John Geddes

Department of Psychiatry, Royal Edinburgh Hospital, Morningside Place, Edinburgh EH10 5HF

Gavin Reynolds

Department of Biomedical Science, University of Sheffield, Sheffield

J.M. Rattenbury

Department of Chemical Pathology, Children's Hospital, Western Bank, Sheffield

Malcolm Peet

Department of Psychiatry, Northern General Hospital, Herries Road, Sheffield, UK

The ratio of the plasma concentration of phenylalanine (PA) to the sum of the plasma concentrations of other large neutral amino acids (LNAA) was calculated in 26 chronic, in-patient schizophrenics who met diagnostic criteria for tardive dyskinesia and 22 patients who did not. No difference in the PA/LNAA ratio was found between the two groups. Small positive correlations were found between age and both PA/LNAA ratio and tardive dyskinesia. Neuroleptic dose correlated negatively with both age and plasma PA/LNAA ratio. No support was found for previous reports of increased plasma PA/LNAA ratio in schizophrenic patients with tardive dyskinesia.

Key Words: tardive dyskinesia • schizophrenia • phenylalanine • large neutral amino acids

Journal of Psychopharmacology, Vol. 6, No. 2, 278-280 (1992)
DOI: 10.1177/026988119200600222


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
J PsychopharmacolHome page
M.A. Richardson, C.J. Flynn, and L. Read
Comment on 'The ratio of plasma phenylalanine to other large neutral amino acids is not a risk factor for tardive dyskinesia'
J Psychopharmacol, January 1, 1993; 7(2): 219 - 220.
[PDF]



Advertisement